🇺🇸 FDA
Patent

US 11542302

Modulators of melanocortin receptors for the treatment of depression and anxiety

granted A61KA61K38/00A61K38/07

Quick answer

US patent 11542302 (Modulators of melanocortin receptors for the treatment of depression and anxiety) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K38/07, A61K38/12, A61K9/0019